Items tagged with Vaccines

WHO public consultation: TB vaccine introduction (post)

The World Health Organization (WHO) released a draft document, Global framework to prepare for country introduction of new TB vaccines for adults and adolescents, aiming to guide countries and global stakeholders in preparing for the introduction of new TB vaccines and scale-up in countries.

BCG vaccine does not protect against COVID-19 in healthcare workers (post)

A world-leading international trial into the immune boosting benefits of the tuberculosis vaccine, BCG, has found it does not protect healthcare workers against COVID-19.

Call for applications: Vaccine Community Advisory Board (post)

The International Treatment Preparedness Coalition (ITPC) and the AIDS Vaccine Advocacy Coalition (AVAC) launched a call for applications for the Vaccine Community Advisory Board (Vax CAB).

Zendal and IAVI announce expanded agreement to partner on development of TB vaccine candidate MTBVAC (post)

• TB kills 1.6 million people a year, causing more deaths than any other single infectious disease apart from COVID-19, and sickens more than 10 million people annually.
• A new TB vaccine is needed to reach global END TB goals.
• MTBVAC is a highly promising vaccine candidate that has the potential to be used as an alternative to BCG vaccination in infants and for prevention of TB disease in adolescents and adults.

PORRIÑO, SPAIN, and NEW YORK, U.S. — MAY 17, 2023 — Spanish biopharmaceutical company Biofabri, a subsidiary of Zendal, and IAVI, an international nonprofit research organization focused on developing vaccines and antibodies against infectious and neglected diseases, today announced the signing of an agreement for end-to-end development of the tuberculosis (TB) vaccine candidate MTBVAC. This agreement provides a framework for the future of the collaboration that the partners first announced in 2021.

TAG webinar: TB vaccine development: The next chapter starts now - webinar materials now available online (post)

Treatment Action Group (TAG) organized a webinar on 13 April 2023 providing an overview of the TB vaccine pipeline, based on TAG’s recent Tuberculosis Vaccines Pipeline Report, including the different candidates at different stages of research, and ongoing and upcoming studies that advocates should closely follow.

Quratis' novel TB vaccine confirms safety, immunogenicity in phase 2 study (post)

22 May 2023 -- Quratis said on Monday that the phase 2a clinical trial results of its novel tuberculosis (TB) vaccine for adults and adolescents, QTP101, showed excellent safety and immunogenicity.

Leicester scientists are hoping to create an improved vaccine to fight TB (post)

Researchers from the University of Leicester are among those hoping to create an improved vaccine to fight tuberculosis as part of a €9 million Euro project.

Fresh insights into how glucose drives TB vaccine responses offer hope for improved efficacy (post)

BCG is a live bacterial vaccine, of limited effectiveness for tuberculosis, but it's the only one we've got. However, scientists in the TB Immunology group at Trinity College Dublin and St. James's Hospital have provided fresh insights into the behaviour of a crucial cell in vaccine mechanisms, which may offer a fresh target for scientists seeking to improve vaccine efficacy.

Germany issues award to IAVI to support development of the MTBVAC TB vaccine candidate (post)

NEW YORK — JULY 6, 2023 — IAVI is pleased to announce a new award has been granted by the German government to help support the late-stage development of a promising tuberculosis (TB) vaccine candidate, MTBVAC.

New TB vaccines could lessen burden of disease in poverty-stricken countries (post)

Introducing novel tuberculosis (TB) vaccines in lower-and middle-income countries (LMICs) has potential to reduce income-based inequalities in health and economic effects, according to a new study published in BMJ Global Health.